A randomised, double-masked phase III/IV study of the efficacy and safety of Avastin(® )(Bevacizumab) intravitreal injections compared to standard therapy in subjects with choroidal neovascularisation secondary to age-related macular degeneration: clinical trial design

BACKGROUND: The management of neovascular age-related macular degeneration (nAMD) has been transformed by the introduction of agents delivered by intravitreal injection which block the action of vascular endothelial growth factor-A (anti-VEGF agents). One such agent in widespread use is bevacizumab...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Praveen J, Bunce, Catey, Tufail, Adnan
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2576049/
https://www.ncbi.nlm.nih.gov/pubmed/18854025
http://dx.doi.org/10.1186/1745-6215-9-56

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2576049/
https://www.ncbi.nlm.nih.gov/pubmed/18854025
http://dx.doi.org/10.1186/1745-6215-9-56

Ejemplares similares